Blog
RSS FeedPosted by Michael Wonder on 28 Oct 2016
Humana spells out its conditional Exondys 51 coverage policy — strings attached
27 October 2016 - Humana’s decision to cover Sarepta’s controversial Duchenne muscular dystrophy drug Exondys 51 (eteplirsen) comes with some ...
Posted by Michael Wonder on 28 Oct 2016
Drug prices, not the health law, top voters’ health priorities for 2017
27 October 2016 - Until this week, when big increases in insurance premiums were unveiled for next year, the federal ...
Posted by Michael Wonder on 28 Oct 2016
The best way to save Obamacare
27 October 2016 - The Affordable Care Act has faced a rocky six months. ...
Posted by Michael Wonder on 28 Oct 2016
In Washington’s drug price fight, plenty of blame to go around
27 October 2016 - Drug price legislation could be attached to FDA bill next year. ...
Posted by Michael Wonder on 28 Oct 2016
Health law tax penalty? I’ll take it, millions say
26 October 2016 - The architects of the Affordable Care Act thought they had a blunt instrument to force people ...
Posted by Michael Wonder on 26 Oct 2016
Crunch time for Obamacare
26 October 2016 - Big rises in premiums will cause most pain away from the exchanges. ...
Posted by Michael Wonder on 26 Oct 2016
Affordable Care Act premium increases are a fixable problem
25 October 2016 - The Affordable Care Act has improved and expanded health insurance to cover millions more Americans. ...
Posted by Michael Wonder on 26 Oct 2016
Seizing on rising costs, Trump says health law is ‘over’
25 October 2016 - Donald J. Trump, desperate for a winning political issue in the final two weeks of the ...
Posted by Michael Wonder on 26 Oct 2016
Novartis CEO sees tougher U.S. drug pricing over next three-five years
25 October 2016 - Novartis expects a more difficult pricing environment for drugs in the United States in the years ...
Posted by Michael Wonder on 26 Oct 2016
Slavitt says tackling drug spending will be top priority for next CMS leader
25 October 2016 - The next leader of the Centers for Medicare and Medicaid Services will have to make drug ...
Posted by Michael Wonder on 26 Oct 2016
Big pharma is gearing up to defend drug prices
25 October 2016 - The skyrocketing costs of prescription drugs has been noticeably absent from discussion in the presidential debates — ...
Posted by Michael Wonder on 26 Oct 2016
Abeona Therapeutics announces fast track designation from FDA for ABO-102 in Sanfilippo syndrome type A
25 October 2016 - Fast track designation added to already granted orphan drug designation by the FDA and EMA, and rare ...
Posted by Michael Wonder on 26 Oct 2016
Portola Pharmaceuticals submits new drug application to U.S. FDA for betrixaban for extended duration prophylaxis of venous thromboembolism in acute medically ill patients
25 October 2016 - Betrixaban, an FDA fast track-designated therapy, would be first anti-coagulant for hospital to home prevention of ...
Posted by Michael Wonder on 25 Oct 2016
FDA approves Merck’s Keytruda (pembrolizumab) in metastatic NSCLC for first-line treatment of patients whose tumours have high PD-L1 expression (tumour proportion score of 50 percent or more) with no EGFR or ALK genomic tumour aberrations
25 October 2016 - FDA also approves a labeling Update for Keytruda for the treatment of patients with metastatic NSCLC ...
Posted by Michael Wonder on 25 Oct 2016
Some health plan costs to increase by an average of 25 percent, U.S. says
24 October 2016 - Premiums for midlevel health plans under the Affordable Care Act will increase by an average of ...